Targeted agents in unresectable HCC: a review of results in 1st and 2nd line

Date 20 October 2018
Event ESMO 2018 Congress
Session ESMO COLLOQUIUM - Systemic therapies in unresectable hepatocellular carcinoma (HCC): 1st and later lines
Topics Hepatobiliary Cancers
Presenter Lorenza Rimassa
Authors L. Rimassa
  • ., Humanitas Clinical and Research Center, Rozzano/IT